Vitasora Health Limited
VHLUF
$0.0581
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 820.40K | 564.40K | 300.10K | 219.80K | 140.20K |
| Total Other Revenue | 404.00K | 394.30K | 379.90K | 379.90K | 379.90K |
| Total Revenue | 1.22M | 958.80K | 680.10K | 599.80K | 520.20K |
| Cost of Revenue | 200.40K | 102.80K | 2.40K | 9.10K | 15.90K |
| Gross Profit | 1.02M | 855.60K | 677.40K | 590.50K | 504.20K |
| SG&A Expenses | 5.91M | 5.56M | 5.18M | 4.84M | 4.53M |
| Depreciation & Amortization | 3.20K | 22.50K | 41.70K | 62.40K | 83.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.22M | 5.79M | 5.31M | 5.00M | 4.71M |
| Operating Income | -5.00M | -4.83M | -4.63M | -4.40M | -4.19M |
| Income Before Tax | -5.00M | -4.85M | -4.68M | -4.45M | -4.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.00 | -4.85 | -4.68 | -4.45 | -4.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.00M | -4.85M | -4.68M | -4.45M | -4.24M |
| EBIT | -5.00M | -4.83M | -4.63M | -4.40M | -4.19M |
| EBITDA | -4.97M | -4.78M | -4.56M | -4.33M | -4.12M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 4.68B | 4.38B | 4.07B | 3.77B | 3.48B |
| Average Diluted Shares Outstanding | 4.68B | 4.38B | 4.07B | 3.77B | 3.48B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |